Pediatricians endorse ban on raw milk products

The American Academy of Pediatrics endorsed a ban on raw milk products in the United States, urging pediatricians to contact local politicians to support a ban and to lobby public health officials for more restrictions.
In a policy statement, the country’s largest professional group of pediatricians said the recommended ban is based on a “multiplicity of data” regarding life-threatening illnesses linked to consumption of raw milk and raw milk products, including cheese.
According to the statement, consumption of raw, unpasteurized milk led to 75 outbreaks consisting of 675 illnesses, 98

Carrot to acquire GreenMan Vision

NEW ORLEANS — Carrot, formerly known as Virtual Field, has an agreement to acquire GreenMan Vision, according to a press release.
GreenMan is the company behind InSightVR, a virtual reality platform that allows patients to see what their vision will look like after IOL implantation. Carrot is a VR visual testing headset used in more than 2,500 clinics.
{{VIDEO}}
The acquisition will add IOL simulation to the visual field testing and diagnostic features of the Carrot platform.
“The partnership between Carrot and GreenMan is great because it allows us access to 2,500 clinics, which gets IOL

What is ‘healthy light’? Permanent transition to LED bulbs may cause potential harms

By 2027, LED lighting will be the predominant source of artificial light available worldwide, after a permanent transition that some physicians are concerned will cause unique, modern-day health risks.
LED, or light-emitting diode, is a type of light that harnesses blue light wavelengths to create visible white light. In November 2023, delegates from 147 countries agreed under the United Nations’ Minamata Convention on Mercury treaty to phase out fluorescent lighting by 2027 due to environmental reasons, including mercury exposure, extreme energy waste and high greenhouse gas emissions.

Should there be a standalone rule-in test for PJI?

Click here to read the Healio Exclusive, “‘We need to look at this like a cancer’: The path to define PJI.”
Diagnosis of a medical condition or disease is not always a simple task.
While conditions like pregnancy or HIV may benefit from the presence of an absolute test with a binary outcome, the majority of medical conditions have different intensities, like rheumatoid arthritis, or may manifest themselves differently in individuals, like multiple sclerosis. Further, some conditions like attention deficit disorder or depression may not have a clear definition or a specific blood test and their

Climate-related skin diseases rising in low-, middle-income countries

More than half of low- and middle-income countries reported climate-related changes in skin disease compared with 28% of high-income nations, a disparity driven in part by unequal healthcare infrastructure and dermatologist access.
The study findings, part of a larger collaboration between the International League of Dermatological Societies (ILDS) and L’Oréal Dermatological Beauty, were reported at the European Academy of Dermatology and Venerology Congress.
“The skin is our front line for climate change because it’s the organ most directly exposed to the environment,” Esther E. Freeman, MD,

FDA clears Motivista for negative symptoms in schizophrenia

The FDA has given Motivista, a prescription digital therapeutic for adults with negative symptoms of schizophrenia, 510(k) clearance as an adjunct to clinician-managed outpatient care, according to a press release from Click Therapeutics.
Current treatments address hallucinations, delusions, disorganized thinking and other positive symptoms, the company said. Motivista (CT-155) is the first FDA-authorized treatment for avolition, anhedonia, asociality and other negative symptoms.
“Schizophrenia is a chronic, disabling condition that affects millions of people in the U.S.,” Tam Dang-Tan, PhD,

CGM may help predict future CVD risk for adults without diabetes

Continuous glucose monitoring may be used to predict cardiovascular disease risk among adults without prevalent type 2 diabetes or CVD, according to findings published in Diabetes Care.
In an analysis of CGM data from 1,356 people without diabetes who participated in the Framingham Heart Study, researchers examined associations between both glycemic measures and CGM profiles and 10-year CVD risk. Bahar Bakhshi, MS, a PhD candidate in molecular and translational medicine at Boston University School of Medicine, said the study showed how glycemic patterns found in CGM data could provide

No survival benefit from community first responder activation

MUNICH — Community first responder activation did not improve 30-day survival in patients with out-of-hospital cardiac arrest, according to the HeartRunner trial presented at the European Society of Cardiology Congress.
“To try to improve survival, community first responder programs are now being implemented worldwide at a rapid pace, meaning that the dispatch center can actually alert community responders, normal citizens close to the cardiac arrest victim, to go start CPR and hopefully bring an [automated external defibrillator] and perform early defibrillation to improve

‘We need healthcare voices’ for health education on TV, online

NEW YORK — Now more than ever, perspectives from people working in healthcare are needed outside of the clinic, according to a speaker at the 2026 Women in Nephrology Leadership Conference.
“We need healthcare voices,” Tara Narula, MD, professor of cardiology at Zucker School of Medicine at Hofstra/Northwell, said during a fireside chat. “We need people who have the training and the background to communicate the science appropriately.”
Narula is also chief medical correspondent for ABC News and a physician author. She touts the mediums of television and other media platforms for their potential

Anti-seizure drugs may affect effectiveness of contraceptives

Roughly one-third of people with epilepsy prescribed certain hormonal contraceptives were also prescribed anti-seizure medications that may reduce the effectiveness of the contraceptives, according to a study published in Neurology.
The research is important for several reasons, Laura Kirkpatrick, MD, pediatric neurologist with the University of Pittsburgh Medical Center, and colleagues wrote.
Many anti-seizure medications (ASMs) can induce hepatic enzymes, which can increase how fast systemic hormonal contraceptives clear from the bloodstream, they wrote.
“Many neurologists, in addition to